esmo 2018: cabozantinib in combination with atezolizumab for rcc
Published 3 years ago • 64 plays • Length 4:13Download video MP4
Download video MP3
Similar videos
-
12:41
cabozantinib in combination with atezolizumab in patients with mcrpc
-
6:57
esmo 2018: cabozantinib after checkpoint blockade for advanced rcc
-
3:53
cabozantinib in combination with immunotherapy for advanced renal cell carcinoma
-
5:05
cabozantinib plus atezolizumab for non-clear cell renal cell carcinoma
-
0:51
dr. pal on the safety profile of cabozantinib/atezolizumab in advanced rcc
-
2:21
cosmic-021, cabozantinib in combination with atezolizumab
-
6:37
cabozantinib in combination with nivolumab demonstrated continued survival and hrqol in arcc pat...
-
2:56
#esmo22 highlights on cabozantinib with nivo and ipi for intermediate/poor risk adv. rcc: cosmic-313
-
8:38
cabozantinib plus atezolizumab for patients with metastatic castration-resistant prostate cancer
-
5:46
cabozantinib plus atezolizumab as first-line therapy for advanced renal cell carcinoma
-
0:48
clinical activity of cabozantinib in patients with rcc with brain metastases
-
1:19
dr. agarwal on the safety of cabozantinib/atezolizumab in mcrpc
-
2:05
esmo 2020 highlights on nivolumab cabozantinib as 1st line therapy for arcc: the checkmate 9er study
-
1:16
dr. mcgregor on combination therapies with nivolumab, cabozantinib, and sunitinib in rcc
-
1:13
dr. agarwal on data with cabozantinib/atezolizumab in mcrpc
-
6:30
cabozantinib plus nivolumab for first-line mrcc
-
3:54
papmet2: cabozantinib with or without atezolizumab in prcc
-
4:22
cabozantinib in combination w/ nivolumab and ipilimumab of imdc intermediate or poor risk signif...
-
3:25
esmo 2018: pt2977 for vhl-associated renal cell carcinoma